It is well established that tumor cells produce a number of NF-κB-dependent cytokines and chemokines that affect the recruitment and phenotype of immune cells in the tumor bed, and the outcome of cancer [9,10,11,12]. This evidence concerns the gene NFKB1 and neoplasm.